Varenicline for Adolescent Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 26, 2018

Study Completion Date

January 26, 2018

Conditions
Nicotine Dependence
Interventions
DRUG

Varenicline

participants \>55 kg will take varenicline/placebo 0.5 mg once daily for 3 days, titrated to 0.5 mg twice daily for 4 days, titrated to 1 mg twice daily thereafter. Participants ≤55 kg will take varenicline/placebo 0.5 mg once daily for 7 days, titrated to 0.5 mg twice daily thereafter.

DRUG

placebo

participants \>55 kg will take varenicline/placebo 0.5 mg once daily for 3 days, titrated to 0.5 mg twice daily for 4 days, titrated to 1 mg twice daily thereafter. Participants ≤55 kg will take varenicline/placebo 0.5 mg once daily for 7 days, titrated to 0.5 mg twice daily thereafter.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT01509547 - Varenicline for Adolescent Smoking Cessation | Biotech Hunter | Biotech Hunter